Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects
- PMID: 6420164
- DOI: 10.1007/BF00542519
Pharmacological interaction between nitroglycerin and aspirin after acute and chronic aspirin treatment of healthy subjects
Abstract
The interaction between nitroglycerin (NTG) and aspirin was investigated in 7 healthy subjects in order to test whether aspirin could block the haemodynamic response to NTG; the doses used were NTG 0.8 mg, and aspirin 0.5 g for chronic and 1 g for acute treatment. The plasma levels of NTG and various physiological parameters (heart rate, diastolic arterial pressure, end diastolic diameter, and end systolic diameter) were measured during the 30 minutes after the administration of NTG. An increase in NTG Cmax and AUC was observed after both aspirin treatment. The changes in physiological parameters produced by NTG were enhanced by the two treatments, although the differences were not statistically significant. The results indicate complex pharmacokinetic and pharmacodynamic interactions between NTG and aspirin.
Similar articles
-
Influence of aspirin on the hemodynamic effects of sublingual nitroglycerin.J Cardiovasc Pharmacol. 1983 Sep-Oct;5(5):874-7. doi: 10.1097/00005344-198309000-00026. J Cardiovasc Pharmacol. 1983. PMID: 6195479 Clinical Trial.
-
The effect of aspirin on the hemodynamic response to nitroglycerin.Am Heart J. 1988 Jul;116(1 Pt 1):77-84. doi: 10.1016/0002-8703(88)90252-9. Am Heart J. 1988. PMID: 3134810 Clinical Trial.
-
Effect of dose and ointment application technique on nitroglycerin plasma concentrations.Pharmacotherapy. 1983 Mar-Apr;3(2 Pt 1):118-24. Pharmacotherapy. 1983. PMID: 6406987
-
Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.Circ Res. 1976 Jul;39(1):127-33. doi: 10.1161/01.res.39.1.127. Circ Res. 1976. PMID: 819179
-
Polyvinylchloride containers do not influence the hemodynamic response to intravenous nitroglycerin.Can J Hosp Pharm. 1993 Aug;46(4):165-70. Can J Hosp Pharm. 1993. PMID: 10128359 Review.
Cited by
-
The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine.Br J Clin Pharmacol. 1987 Jan;23(1):103-5. doi: 10.1111/j.1365-2125.1987.tb03018.x. Br J Clin Pharmacol. 1987. PMID: 3101725 Free PMC article. No abstract available.
-
Nitroglycerin disposition in human blood.Eur J Clin Pharmacol. 1985;29(2):169-75. doi: 10.1007/BF00547417. Eur J Clin Pharmacol. 1985. PMID: 3935462
-
The role of vascular endothelium in nitroglycerin-mediated vasodilation.Br J Clin Pharmacol. 2019 Feb;85(2):377-384. doi: 10.1111/bcp.13804. Epub 2018 Dec 3. Br J Clin Pharmacol. 2019. PMID: 30378151 Free PMC article. Clinical Trial.
-
Clinical pharmacokinetics of glyceryl trinitrate following the use of systemic and topical preparations.Clin Pharmacokinet. 1987 Jan;12(1):1-11. doi: 10.2165/00003088-198712010-00001. Clin Pharmacokinet. 1987. PMID: 3102143 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources